ldn and tirzepatide Have you tried for Long COVID yet? In a Stanford study, 54% of people with Long COVID saw improvements in fatigue, brain fog, sleep after taking Low-Dose Naltrexone (LDN). It What is LDN? - Low

Retatrutide inherits every structural driver of discontinuation that semaglutide and tirzepatide have, and it adds one of its own: the dose-dependent dysesthesia signal at 9 mg and 12 mg in TRIUMPH-4, reported at roughly 20.9% at the 12 mg dose

Discontinuation Rates Treatment Discontinuation Due to Adverse Events: Retatrutide 9mg: 12.2% Retatrutide 12mg: 18.2% Placebo: 4.0% Interestingly, some discontinuations were attributed to "perceived excessive weight loss" participants felt they were losing weight too rapidly or had reached their desired weight and chose to discontinue

It is believed to be accurate at the time of posting and is subject to change

You can also message your provider anytime through the portal